Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC

por Mallet, R., Decazes, P., Modzelewski, R., Lequesne, J., Vera, P., Dubray, B., Thureau, S.
Publicado 2021

Reproducibility of measurements of potential doubling time of tumour cells in the multicentre National Cancer Institute protocol T92-0045

por Wilson, G D, Paschoud, N, Pavy, J-J, Weber, K, Weber, P, Dubray, B, Coucke, P A
Publicado 1999